Nanomedicine News

RSS

Biodegradable Nanomedicine Could Selectively Destroy Ovarian Cancer Cells Left Behind After Surgery

Scientists are investigating a biodegradable nanomedicine that can selectively destroy ovarian cancer cells left behind after surgery. These findings are a step forward in the development of targeted therapies for hard-to-treat cancers.

30 Oct 2015

PEN Launches Graphene-Based Product for Diagnostic Imaging Applications

PEN Inc., a global leader in enhanced performance products enabled by nanotechnology to solve everyday problems, today announced the launch of a new graphene-based product for use in the production of nuclear pharmaceuticals used as diagnostic imaging biomarkers.

30 Oct 2015

Nanoparticle-Based Radiotherapeutic Bandage Being Evaluated to Treat Squamous Cell Carcinoma

A radiotherapeutic bandage is being evaluated by researchers for efficacy against squamous cell carcinoma (SCC) in an animal model. These results could confirm the viability of a new and improved strategy for the radiotherapeutic treatment of skin cancer in the clinic.

29 Oct 2015

Pharmasyntez Executes First Order of Oasmia’s Paclical Cancer Product in Russia

Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, announced today that it its distribution partner, Pharmasyntez, has executed the first order of Paclical, Oasmia’s lead cancer product.

29 Oct 2015

New Nanoparticle Targets and Destroys Cells That Cause Cardiac Arrhythmia

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.

29 Oct 2015

Biodegradable Polymer Implant Reinforced with Montmorillonite Clay Nanoparticles Improves Outcomes for Patients

A plastic derived from cornstarch combined with a volcanic ash compound, Montmorillonite clay, could help heal the bones of hundreds of thousands of patients with orthopedic injuries who need bone replacement after tumor removal, spinal fusion surgery or fracture repair.

29 Oct 2015

Celator VYXEOS Honored with Nanomedicine Award 2015

Celator Pharmaceuticals, Inc. today announced that VYXEOS™ (formerly referred to as CPX-351) was recognized with the Nanomedicine Award 2015. This award recognizes projects or products that have been developed using innovative solutions based on nanotechnology.

28 Oct 2015

Novel Nanotherapeutic Method Quickly Dissolves Clots Obstructing Blood Vessels in the Brain

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.

28 Oct 2015

BIND Therapeutics’ Four Abstracts Accepted for Presentation at AACR-NCI-EORTC International Conference

BIND Therapeutics, Inc., a clinical-stage nanomedicine company developing targeted and programmable therapeutics called Accurins™, today announced that four abstracts have been accepted for presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held in Boston, November 5-9, 2015.

27 Oct 2015

Senior Scientific Awarded Chinese Patent for Nanoparticle-Based Early Cancer Detection Technology Platform

Senior Scientific, LLC, a unit of Manhattan Scientifics and a developer of nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the Company has recently been granted a patent by the Chinese Patent Office, Patent No. CN102695473 A, covering the "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof."

27 Oct 2015

Nanomedicine News

Biodegradable Nanomedicine Could Selectively Destroy Ovarian Cancer Cells Left Behind After Surgery

PEN Launches Graphene-Based Product for Diagnostic Imaging Applications

Nanoparticle-Based Radiotherapeutic Bandage Being Evaluated to Treat Squamous Cell Carcinoma

Pharmasyntez Executes First Order of Oasmia’s Paclical Cancer Product in Russia

New Nanoparticle Targets and Destroys Cells That Cause Cardiac Arrhythmia

Biodegradable Polymer Implant Reinforced with Montmorillonite Clay Nanoparticles Improves Outcomes for Patients

Celator VYXEOS Honored with Nanomedicine Award 2015

Novel Nanotherapeutic Method Quickly Dissolves Clots Obstructing Blood Vessels in the Brain

BIND Therapeutics’ Four Abstracts Accepted for Presentation at AACR-NCI-EORTC International Conference

Senior Scientific Awarded Chinese Patent for Nanoparticle-Based Early Cancer Detection Technology Platform

Nanopore-Based Sensor Enables Rapid and Precise Disease Diagnosis

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Brain-Inspired Nano-Tech Promises New Era for Electronics

Conversations on AFM: Applications of BioAFM in Life Science

Conversations on AFM: The Technology and History Behind AFM and SPM

Recent Advances in High-Speed Atomic Force Microscopy to Improve Research Into Protein Dynamics

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials